Health Care · S&P 500

Pfizer

A major U.S. pharmaceutical company that develops and markets vaccines and prescription medicines. S&P 500 constituent. Sector: Health Care (Pharmaceuticals). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

PFE Updated Jul 11, 2026 2 AI consumers· 1 recurring

Annual return · 2026-07-10'21+66.7%'22-10.4%'23-41.3%'24-2.2%'25+0.6%YTD+0.3%
Money in·
Pfizer~$63.6B
Money out·

Financials & Segments

  • Total revenue · ~$63.6B (FY2024)
  • Segments · Primary Care (vaccines & internal medicine) · Specialty Care · Oncology

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com